ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

This study has been terminated.

( Slow recruitment )

Study NCT00461266 Information provided by Hoffmann-La Roche

First Received: April 16, 2007 Last Updated: March 19, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	May 2009
Estimated Primary Completion Date:	No date given